Home: PCU
3|2003: A CME Audio Series and Activity
Prostate Cancer Update: A CME Audio Series and Activity
STATEMENT OF NEED/TARGET AUDIENCE
Prostate cancer is one of the most rapidly evolving fields in urology. Published
results from
clinical trials lead to the emergence of new surgical and radiation therapy
techniques and
therapeutic agents, along with changes in the indications for existing treatments.
In order to offer
optimal patient care — including the option of clinical trial participation — the
practicing
urologist and radiation oncologist must be well-informed of these advances.
To bridge the gap
between research and patient care, Prostate Cancer Update utilizes one-on-one
discussions with
leading urologic oncology investigators. By providing access to the latest
research developments
and expert perspectives, this CME program assists urologists and radiation
oncologists in the
formulation of up-to-date clinical management strategies.
GLOBAL LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:
- Critically evaluate the clinical implications of emerging clinical trial
data in prostate cancer
treatment.
- Inform patients about the specific risks and benefits of local and systemic
therapies.
- Provide individualized counseling to patients regarding the choice and
timing of endocrine
therapy.
- Offer patients information regarding their prognosis with and without
various therapeutic
options.
Issue 3, 2003, of Prostate Cancer Update consists of discussions with
three research leaders on a
variety of important issues, including intermittent androgen deprivation,
salvage radiation and
hormonal therapy, early versus delayed hormonal therapy and watchful
waiting.
SPECIFIC LEARNING OBJECTIVES FOR ISSUE 3
Upon completion of this activity, participants should be able to:
- Develop an awareness of ongoing clinical trials of intermittent versus
continuous androgen
deprivation in order to counsel patients about their eligibility
for participation.
- Evaluate research leader perspectives and clinical data related to salvage
radiation and hormonal
therapy in order to counsel patients about treatment options
after failure of definitive local therapy.
- Review clinical trial data and research leader views on early versus
deferred hormonal therapy in
order to offer patients choices after local therapy.
- Evaluate the role of watchful waiting versus local therapy to determine
for whom it would be an
appropriate option.
- Review the advantages and disadvantages of different methods for delivering
radiation therapy.
ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance
with the Essential Areas and
Policies of the Accreditation Council for Continuing
Medical Education (ACCME) by NL
Communications, Inc. NL Communications, Inc is accredited
by the ACCME to provide continuing
medical education for physicians.
CREDIT DESIGNATION STATEMENT
NL Communications, Inc designates this educational
activity for a maximum of 3 category 1 credits
toward the AMA Physician’s Recognition Award.
Each physician should claim only credits that he/she
actually spent on the activity.
|
